Trialect

Active

Chronic obstructive pulmonary disease (COPD)

Hospital Universitari Vall d'Hebron (HUVH)

Main Areas of Interest

The main clinical areas of our group are:

Chronic obstructive pulmonary disease (COPD)
Alpha1-antitrypsin deficiency (AATD)

Techniques You Will Learn

During our traineeship program you will learn:

Identification, diagnosis, management and follow-up of COPD patients in a specialized outpatient clinic
Identification, diagnosis, management and follow-up of patients with alpha1-antitrypsin deficiency in a specialized outpatient clinic
Learning of clinical research tools and possibility of publishing articles from databases of our outpatient patients.
Learning of laboratory techniques for the diagnosis of AATD

Modules

4-12 week program

At the beginning of the program, fellows will be supported in to settle down into their new environment (find appropriate accommodation, locate amenities, etc.). In the hospital, a desk space will be allocated and facilities for personal welfare (access to dining room, medical gown) will be provided by our institution.

Additionally, a group meeting will take place at the beginning in order to have an initial meeting with other fellows. Posteriorly, a weekly meeting will be programmed to discus about the fellow´s progress during the traineeship.

The fellow will be fully trained to all activities of the group and will be able to attend to the specialized outpatient clinic. As well, the fellow will have access to different units such as clinical laboratory, lung function test and other outpatient clinics if the fellow wants. The fellow will also be engaged in clinical research and writing scientific articles.

The fellow will have the opportunity to partake in other group meetings and activities of another pneumology units within our hospital: Occupational respiratory diseases, lung transplantation, chronic respiratory infections (Cystic fibrosis and bronchiectasis).

Towards the end of the training I will have a meeting with the fellow to discuss plans to publish their clinical work (if enough data collected) or disseminate their findings in a future conference.

All throughout the training, any peculiar challenges or specific requests of a fellow will be fully considered, in order to ensure that a responsive, relevant and adequate training plan is developed for them.

Program Fee


Total Number of Modules
Time duration of Each module	minutes
Total Program Cost	$0

Who Can Apply

Host Details

Host Name: Marc Miravitlles

Affiliation: Hospital Universitari Vall d'Hebron (HUVH)

Address: Passeig de la Vall d'Hebron, 119, 08035 Barcelona, Spain

Website URL: https://hospital.vallhebron.com/ca

Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.